林东海

发布日期:2016-11-04     浏览次数:次   

教授、博士生导师
电话:0592-2186078 (办公室)
传真:0592-2186078
电子邮箱:dhlin@xmu.edu.cn
课题组主页:
https://dhlin.xmu.edu.cn/

个人简历:

2011年入选“福建省 (A类)”

2010年5月至今,维多利亚vic309官网,“闽江学者”特聘教授,博导

2009年,入选“上海市优秀学科带头人计划(A类)”,作为负责人筹建维多利亚vic309官网高场核磁共振中心

2003年4月-2010年4月,中科院上海药物研究所,研究员,博导

2001年6月-2003年5月,香港科技大学生物核磁共振中心,研究助理

1998年3月-2001年5月,美国City of Hope National Medical Center生物核磁共振实验室,博士后

1995年3月-1998年2月,维多利亚vic309官网化学系核磁共振实验室,副教授;日本科学振兴会JSPS,特别研究员

1993年3月-1995年2月,中科院武汉物理研究所,博士后

1989年9月-1993年2月,维多利亚vic309官网化学系,博士生,获得博士学位

1986年9月-1989年7月,维多利亚vic309官网物理系,硕士生,获得硕士学位

1984年8月-1986年8月,电子工业部第24研究所,技术员

1980年9月-1984年7月,维多利亚vic309官网物理系,本科,学士


荣获2006度中国“王天眷”波谱学奖(2006年);

“上海市优秀学科带头人计划(A类)”入选者(2009年);

维多利亚vic309官网“闽江学者”特聘教授(2009年);


研究兴趣:

一、利用NMR和LC-MS技术开展代谢组学研究,包括:(1) 阐述重大疾病的代谢特征,发展早期诊断和术后检测方法;(2) 阐述疾病发生发展过程中代谢模式和谢物水平的变化和受扰动的代谢通路,揭示发病的分子机制,寻找逆转病理代谢状态的方法;(3)评估药物的药效和毒性,阐明所干预的代谢通路和作用机制;(4)运动人体的代谢特征与运动影响的特征性代谢物和作用的重要代谢通路。

二、主要利用生物NMR和X-射线晶体衍射技术开展结构生物学研究,包括:(1) 测定蛋白质、多肽及其复合物的溶液结构或晶体结构;(2) 研究蛋白质、多肽与配体的相互作用;(3) 测定蛋白质的动力学;(4)基于结构的药物筛选,等等。

近期主要代表论著: 

  1. [1] C. Guo#, Z. Wu, H. Xu, Y. Zhou, B. Jiang, D. Lin*, Structural basis of cefotetan up-regulating human RKIP-mediated Ras/Raf1/MEK/ERK signal pathway. Acta Biochimica et Biophysica Sinica, in press (2022). (IF 3.848)

  2. [2] C. Guo#, H. Zhang#, W. Lin, H. Chen, T. Chang, Z.Wu, J.Yu, D. Lin*, ADP-induced conformational transition of human adenylate kinase 1 is triggered by suppressing internal motion of α3α4 and α7α8 fragments on the ps-ns timescale. Biomolecules, in press (2022). (IF 4.879)

  3. [3] W. Shao*, B. Liu, C. Huang, Y. Wu, Z. Zhang, D. Lin*, β-hydroxybutyrate in cardiovascular diseases a minor metabolite of great expectations. Frontiers in Molecular Biosciences, in press (2022). (IF 5.246)

  4. [4] B. Jiang, J. Zhang, G. Zhao, M. Liu, J. Hu, F. Lin, J. Wang, W. Zhao, H. Ma, C. Zhang, C. Wu, L. Yao, Q. Liu, X. Che, Y. Cao, Y. Zheng, C. Zhang, A. Han, D. Lin, Q. Li*, Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis, Molecular Cell, 82(3): 1-15 (2022). (IF 17.970)

  5. [5] Z. Wang, D. Guo, Z. Tu, Y. Huang, Y. Zhou, J. Wang, L. Feng, D. Lin, Y. You, T. Agback, V. Orekhov, X. Qu, A Sparse Model-inspired Deep Thresholding Network for Exponential Signal Reconstruction-Application in Fast Biological Spectroscopy, IEEE Transactions on Neural Networks and Learning Systems10.1109/Tnnls.2022.3144580 (2022). (IF 10.451)

  6. [6] Q. Kong#, J. Gu#, R. Lu, C. Huang, X. Hu, W. Wu, D. Lin*, NMR-based metabolomic analysis of sera in mouse models of CVB3-induced viral myocarditis and dilated cardiomyopathy, Biomolecules, DOI: 10.3390/biom12010112 (2022). (IF 4.879)

  7. [7] P. Cui, X. Li, C. Huang, Q. Li, D. Lin*, Metabolomics and its applications in cancer cachexia Metabolomics and its applications in cancer cachexia, Frontiers in Molecular Biosciences, DOI: 10.3389/fmolb.2022.789889 (2022). (IF 5.246)

  8. [8] Y. Zhou#, F. Lin#, T. Wan#, A. Chen#, H. Wang#, B. Jiang, W. Zhao, S. Liao, S. Wang, G. Li, Z. Xu, J. Wang, J. Zhang, H. Ma, D. Lin, Q. Li*, ZEBI enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM, Theranostics, 11 (12): 5926-5938 (2021). (IF 11.556)

  9. [9] J. Zhuang, S. Fan, C. Guo, L. Feng, H. Wang, D. Lin*, X. Liao*, Crystal Structure of the Polyketide Cyclase from Mycobacterium tuberculosis, Acta Biochimica et Biophysica Sinica, in press (2021). (IF 3.848)

  10. [10] Y. Su, J. Li, W. Zhang, J. Ni, R. Huang, Z. Wang, S. Cheng, Y. Wang, Z. Tian, Q. Zhou, D. Lin, W. Wu, C. Tang, X. Liu, J. Lu, and Y. Yao*, Methylation of PhoP by CheR regulates Salmonella virulence, mBio, DOI:10.1128/mBio.02099-21 (2021). (IF 7.867)

  11. [11] T. Jiang#, Q. Du#, C. Huang, W. Xu, P. Guo, W. Li, X. Xie, Y. Guo, D. Liu*, D. Lin*, NMR-based metabolomic analysis on the protective effects of apolipoprotein A-I mimetic peptide against contrast media-induced endothelial dysfunction, Molecules, 265123 (2021). (IF 4.411)

  12. [12] Y. Guo, W. Li, M. Qian, T. Jiang, P. Guo, Q. Du, N. Lin, X. Xie, Z. Wu, D. Lin, D. Liu*, D-4F Ameliorates Contrast Media-Induced Oxidative Injuries in Endothelial Cells via the AMPK/PKC Pathway. Front Pharmacol., 11: 556074(2021). (IF 5.810)

  13. [13] L. Zhou, T. Zhang, W. Shao, R. Lu, L. Wang, H. Liu, B. Jiang, S. LiH. ZhuoS. Wangle Q. Li, C. Huang*, D. Lin*, Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release, Skeletal Muscle, 2021, 11:1-17, DOI10.1186/s13395-021-00274-5. (IF 4.912)

  14. [14] S. Fan, J. Zhuang, C. Guo, D. Lin*, X. Liao*, 1H, 13C, 15N backbone and side-chain chemical shift assignments of the polyketide cyclase from Mycobacterium Tuberculosis, Biomolecular NMR Assignments, DOI: 10.1007/s12104-021-10036-5 (2021). (IF 0.746)

  15. [15] L. Zhou, R, Lu, C. Huang, D. Lin*, Taurine protects C2C12 myoblasts from impaired cell proliferation and myotube differentiation under cisplatin-induced ROS exposure, Frontiers in Molecular Biosciences, 8: 685362. DOI: 10.3389/fmolb.2021.685362 (2021). (IF 5.246)

  16. [16] L. Xu, H. Song, Q. Qiu, T. Jiang, P. Ge, Z. Su, W. Ma, R. Zhang, C. Huang, S. Li*, D. Lin*, J. Zhang*, Different expressions of HIF-1α and metabolism in brain and major visceral organs of acute hypoxic mice. International Journal of Molecular Science, 22: 6705, DOI: 10.3390/ijms22136705 (2021) (IF 5.923)

  17. [17] T. Song, Y. Guo, Z. Xue, Z. Guo, Z. Wang, D. Lin*, H. Zhang, H. Pan, X. Zhang, F. Yin, H. Wang, L. Uwituze, Z. Zhang*, Small-molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in CML cells overcomes BCR-ABL-independent TKI resistance, Leukemia, 35(10):2862-2874DOI: 10.1038/s41375-021-01283-5 (2021). (IF 11.528)

  18. [18] H. Zhang, Q. Zhou, C. Guo, L. Feng, H. Wang, X. Liao, D. Lin*,
    Structural Basis for the C-terminal Domain of Mycobacterium Tuberculosis Ribosome Maturation Factor RimM to Bind Ribosomal Protein S19,
    Biomolecules, 11(4): 597. DOI: 10.3390/biom11040597 (2021). (IF 4.879)

  19. [19] H. Zhang, C. Guo*, D. Lin*, 1H, 13C, 15N backbone and side-chain NMR assignments of the C-terminal Domain of Mycobacterium Tuberculosis Ribosome Maturation Factor RimM, Biomolecular NMR Assignments, DOI10.1007/s12104-021-10032-9 (2021). (IF 0.746)

  20. [20] Q. Zhang, H. Zhang, F. Zheng, R. Liu, X. Liao, C. Guo*, D. Lin* 1H, 13C, 15N backbone and side-chain resonance assignments of the pathogenic G131V mutant of human prion protein (91-231). Biomolecular NMR Assignments, (2021). (IF 0.746)


 

 


上一条:韩守法 下一条:宋彦龄